X4 Pharmaceuticals Inc
XFOR
NASDAQ
Biotechnology
$4.22
USD
-0.07 (-1.63%)
At close: Aug 14, 2026, 4:00 PM EDT
Market Cap $404.63M
Volume 840.9K
Price Target
$11.00 – $12.00
USD
The 2 analysts offering 1-year price forecasts have a max estimate of $12.00 and a min estimate of $11.00.
Past 2Y
1Y Forecast
Price Targets
Average Target
$11.50
-$0.5 vs prior
Implied Upside
+172.5%
-11.9% vs prior
Analyst Covering
2
+1 vs prior period
Consensus
Buy
Unchanged vs prior
Signal Quality
Consensus Freshness
67%
Most ratings are recent - from the last 3 months
Analyst Agreement
High
Targets are closely clustered - analysts largely agree
Mean vs Median
$0 Gap
Median and average are closely aligned - few outliers skewing the consensus
Analyst Consensus
Strong Sell
Hold
Strong Buy
Buy
2 Buy
0 Hold
0 Sell
Rating Breakdown
Strong Buy
0
Buy
2
Hold
0
Sell
0
Strong Sell
0
2 analysts · last 3 months
Covering Analysts
Unlock each analyst's profile, success rate + price targets
Free shows the consensus and each analyst's current rating.
| Analyst | Firm | Rating | Action | Date | Success Rate | Price Target | Implied Upside |
|---|---|---|---|---|---|---|---|
Derek Archila | Wells Fargo | Buy | Initiated | 1 month ago | Plus | Plus | Plus |
Thomas Smith | Leerink Partners | Buy | Initiated | 2 months ago | Plus | Plus | Plus |
Frequently Asked Questions
